Mr. George Robinson reports

RAVENQUEST COMPLETES NON-BROKERED PRIVATE PLACEMENT

Ravenquest Biomed Inc. has completed a non-brokered private placement of 4.14 million units at a price of 50 cents per unit for gross proceeds of $2.07-million.

Each unit consists of one common share of the company and one share purchase warrant. Each warrant entitles the holder to purchase one additional common share of the company at a price of 60 cents per share for a period of two years.

The proceeds of the financing will be used for general corporate purposes. In connection with completion of the financing, the company has paid finders' fees of $144,900 and issued 289,800 warrants as consideration for referring subscribers to the financing. All securities issued in connection with the financing are subject to a four-month-and-one-day statutory hold period in accordance with applicable securities laws.

Ravenquest further announces it has engaged enPercept Inc., an influencer marketing agency, to provide market awareness services for a four-month period at a fee of $115,000 per month, to be paid in common shares for service at prevailing market prices. Securities issued are subject to a four-month-and-one-day statutory hold period in accordance with applicable securities laws.

About Ravenquest Biomed Inc.

Ravenquest is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services and consulting, and specialized research and development. Ravenquest is a licensed producer with facilities located in Markham, Ont., and Edmonton, Alta. Ravenquest maintains a research partnership with McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.

We seek Safe Harbor.